$0.04
6.58%
Nasdaq, Fri, Sep 27 2024
ISIN
CA88830X8199
Symbol
TMDI

Titan Medical Inc. Stock price

$0.04
-0.00 3.80% 1M
-0.01 20.59% 6M
-0.02 33.61% YTD
-0.06 60.76% 1Y
-1.54 97.44% 3Y
-0.98 96.03% 5Y
-65.90 99.94% 10Y
Nasdaq, Closing price Fri, Sep 27 2024
+0.00 6.58%
ISIN
CA88830X8199
Symbol
TMDI
Sector

Key metrics

Market capitalization $4.33m
Enterprise Value $1.53m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 3.40
P/S ratio (TTM) P/S ratio 9.62
P/B ratio (TTM) P/B ratio 1.59
Revenue growth (TTM) Revenue growth -97.30%
Revenue (TTM) Revenue $450.00k
EBIT (operating result TTM) EBIT $-2.30m
Free Cash Flow (TTM) Free Cash Flow $-5.81m
Cash position $3.90m
EPS (TTM) EPS $-0.04
Short interest 0.05%
Show more

Is Titan Medical Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Titan Medical Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Titan Medical Inc. forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a Titan Medical Inc. forecast:

Buy
100%

Financial data from Titan Medical Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
0.45 0.45
97% 97%
100%
- Direct Costs 0.12 0.12
79% 79%
27%
0.33 0.33
98% 98%
73%
- Selling and Administrative Expenses 3.10 3.10
72% 72%
689%
- Research and Development Expense -0.59 -0.59
104% 104%
-131%
-2.18 -2.18
77% 77%
-484%
- Depreciation and Amortization 0.12 0.12
79% 79%
27%
EBIT (Operating Income) EBIT -2.30 -2.30
77% 77%
-511%
Net Profit -5.05 -5.05
59% 59%
-1,122%

In millions USD.

Don't miss a Thing! We will send you all news about Titan Medical Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Titan Medical Inc. Stock News

Neutral
GlobeNewsWire
more than one year ago
TORONTO, Ontario, May 15, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF) is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Order s (“NP 12-203”).
Neutral
GlobeNewsWire
more than one year ago
TORONTO, Ontario, May 01, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF) is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Order s (“NP 12-203”).
Neutral
GlobeNewsWire
more than one year ago
TORONTO, Ontario, April 17, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF) is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”).
More Titan Medical Inc. News

Company Profile

Titan Medical, Inc. engages in the research and development of SPORT Surgical System, a computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS) comprising single-port robotic surgical system. The company was founded on July 28, 2008 and is headquartered in Toronto, Canada.

Head office Canada
CEO Paul Cataford
Employees 16
Founded 2008
Website www.titanmedicalinc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today